Perrin P J, Fidelus R K, Lee K M, Phillips S M
Immune Cell Biology Program, Navy Medical Research Institute, Bethesda, MD 20889-5955, USA.
Ther Immunol. 1994 Oct;1(5):257-67.
We have previously studied a T-cell derived soluble suppressor factor (TseF) which regulates immunopathology in schistosomiasis. The current studies address the mechanism whereby TseF suppresses the functional immune response in murine schistosomiasis. We assessed three stages of the immune response: (1) initial antigenic recognition using the criteria of antigen-mediated cell division or blast transformation (AMBT); (2) intracellular differentiation utilizing criteria of glutathione (GSH) and ornithine decarboxylase (ODC) production; and (3) efferent function utilizing criteria of in vitro granuloma formation (IVGF). We studied these three criteria of immune reactivity during the course of schistosomiasis. Lymphoid cells from acutely infected animals demonstrated high levels of antigen-mediated cell division and in vitro granuloma formation; ODC and GSH levels were low. Cells obtained from chronically infected animals demonstrated lower antigen-mediated cell division and granuloma formation; however, ODC and GHS levels were much higher, indicating that cells obtained from chronically infected animals are in a non-reactive state of increased activation. TseF strongly increased GSH and ODC levels in lymphocytes obtained from acutely infected animals, and this effect was augmented by the presence of antigen. However, TseF had minimal effects on initial antigenic recognition, and profoundly suppressed the effector function. The relationship between the effects of TseF on antigen recognition and function was regulated at the clonal level. TseF function required the generation of GSH. Since TseF is produced in chronic disease under conditions of decreased immunological reactivity, the alterations of GSH and ODC activity, induced by TseF, may be responsible for the regulation of immunopathology.
我们之前研究了一种由T细胞衍生的可溶性抑制因子(TseF),它可调节血吸虫病中的免疫病理学。目前的研究探讨了TseF抑制小鼠血吸虫病功能性免疫反应的机制。我们评估了免疫反应的三个阶段:(1)使用抗原介导的细胞分裂或母细胞转化(AMBT)标准进行初始抗原识别;(2)利用谷胱甘肽(GSH)和鸟氨酸脱羧酶(ODC)产生标准进行细胞内分化;(3)利用体外肉芽肿形成(IVGF)标准进行传出功能评估。我们在血吸虫病病程中研究了这三个免疫反应性标准。急性感染动物的淋巴细胞表现出高水平的抗原介导细胞分裂和体外肉芽肿形成;ODC和GSH水平较低。从慢性感染动物获得的细胞表现出较低的抗原介导细胞分裂和肉芽肿形成;然而,ODC和GHS水平要高得多,这表明从慢性感染动物获得的细胞处于激活增加的无反应状态。TseF显著提高了急性感染动物淋巴细胞中的GSH和ODC水平,并且抗原的存在增强了这种作用。然而,TseF对初始抗原识别的影响最小,并深刻抑制了效应器功能。TseF对抗原识别和功能的影响之间的关系在克隆水平上受到调节。TseF的功能需要GSH的产生。由于TseF是在免疫反应性降低的慢性疾病中产生的,TseF诱导的GSH和ODC活性的改变可能是免疫病理学调节的原因。